Skip to content

Overview

Bank of China contributes to $1.5 billion USD syndicated revolving credit facility to Zimmer Biomet Holdings for general corporate purposes in 2022 (Linked to Record ID#110628, #110629, #110630 and #110632)

Commitments (Constant USD, 2023)$64,426,304
Commitment Year2022Country of ActivityUnited StatesDirect Recipient Country of IncorporationUnited StatesOverseas JurisdictionUnited StatesSectorHealthFlow TypeLoan

Status

Project lifecycle

Completion

Pipeline: PledgePipeline: CommitmentImplementationCompletion

Timeline

Key dates

Commitment date
Aug 19, 2022
Last repayment (originally scheduled)
Aug 18, 2027

Stakeholders

Organizations involved in projects and activities supported by financial and in-kind transfers from Chinese government and state-owned entities

Ultimate beneficial owners

At least 25% host country ownership

Funding agencies

State-owned Commercial Banks

  • Bank of China (BOC)

Cofinancing agencies

Private Sector

  • Bank of America, N.A.
  • Barclays Bank PLC
  • BNP Paribas S.A.
  • Citibank, N.A.
  • Credit Suisse (Schweiz) AG (also known as Credit Suisse (Switzerland) Ltd.)
  • DNB Capital LLC
  • DZ Bank AG
  • Goldman Sachs Bank USA
  • HSBC Bank PLC
  • JPMorgan Chase Bank, N.A. (Chase Bank, formerly the Chase Manhattan Bank)
  • Lake City Bank
  • Mizuho Bank, Ltd.
  • MUFG Bank, Ltd. (Formerly Bank of Tokyo-Mitsubishi UFJ, Ltd. (BTMU))
  • Royal Bank of Canada (RBC)
  • Sumitomo Mitsui Banking Corporation (SMBC)
  • TD Bank, N.A.
  • The Northern Trust Company
  • U.S. Bank National Association
  • UniCredit Bank AG
  • Wells Fargo Bank N.A.

State-owned Commercial Banks

  • Agricultural Bank of China (ABC)

Receiving agencies

Private Sector

  • Zimmer Biomet Holdings, Inc.

Loan description

ABC and BOC contribute to $1.5 billion USD syndicated revolving credit facility to Zimmer Biomet Holdings for general corporate purposes in 2022

Interest rate (t₀)4.14927%Interest typeVariable Interest RateMaturity5 years

Narrative

Full Description

Project narrative

On November 1, 2019, financial close was reached on a deal in which a syndicate of 23 banks — including Bank of China — entered into a $1.5 billion USD syndicated loan agreement with Zimmer Biomet Holdings, Inc., a U.S.-based medical device company that develops, manufactures, and markets orthopedic reconstructive products, among other healthcare solutions — for general corporate purposes. The maturity of the loan is 5 years, and the interest rate is LIBOR plus an applicable margin. The proceeds were used by the borrower for general corporate purposes, which may include refinancing of existing debt, working capital, or other corporate expenditures. While Bank of China contributed to this loan (Record ID#110628), the following lenders also participated: JPMorgan Chase, Bank of America, N.A., Wells Fargo Bank, National Association, BNP Paribas, Citibank, N.A., Credit Suisse AG (Cayman Islands Branch and Switzerland Ltd.), DNB Capital LLC, HSBC Bank USA, N.A., Mizuho Bank, Ltd., MUFG Bank, Ltd., Royal Bank of Canada, Sumitomo Mitsui Banking Corporation, Bank of Montreal, Goldman Sachs Bank USA, U.S. Bank National Association, TD Bank, N.A., UniCredit Bank AG (New York Branch), DZ Bank AG (New York Branch), PNC Bank, National Association, The Northern Trust Company, and Lake City Bank. On August 20, 2021, financial close was reached on a deal in which a syndicate of 22 banks — including Agricultural Bank of China and Bank of China — entered into a $1.5 billion USD syndicated loan agreement with Zimmer Biomet Holdings, Inc., a U.S.-based medical device company that develops, manufactures, and markets orthopedic reconstructive products, dental implants, and related surgical equipment — for general corporate purposes. The maturity of the loan is 5 years, and the interest rate is LIBOR plus an applicable margin. The proceeds were used by the borrower for general corporate purposes, which may include working capital, refinancing existing debt, or other general business needs. While Agricultural Bank of China (Record ID#110630) and Bank of China contributed to this loan (Record ID#110629), the following lenders also participated: JPMorgan Chase Bank, N.A., Citibank, N.A., Mizuho Bank, Ltd., Bank of America, N.A., Barclays Bank PLC, BNP Paribas, DNB Capital LLC, HSBC Bank USA, N.A., Goldman Sachs Bank USA, Morgan Stanley Bank, N.A., MUFG Bank, Ltd., Royal Bank of Canada, Sumitomo Mitsui Banking Corporation, Credit Suisse (Switzerland) Ltd., TD Bank, N.A., UniCredit Bank AG (New York Branch), US Bank, National Association, DZ Bank AG (New York Branch), The Northern Trust Company, and Lake City Bank. On August 19, 2022, financial close was reached on a deal in which a syndicate of 22 banks — including Agricultural Bank of China and Bank of China — entered into a $1.5 billion USD syndicated loan agreement with Zimmer Biomet Holdings, Inc., a U.S.-based medical device company that develops, manufactures, and markets orthopedic reconstructive products, dental implants, and related surgical equipment — for general corporate purposes. The maturity of the loan is 5 years, and the interest rate is LIBOR plus an applicable margin. The proceeds were used by the borrower for general corporate purposes, which may include working capital, refinancing of existing debt, or other corporate needs. While Agricultural Bank of China (Record ID#110632) and Bank of China contributed to this loan (Record ID#110631), the following lenders also participated: JPMorgan Chase Bank, N.A., Citibank, N.A., Mizuho Bank, Ltd., Bank of America, N.A., Barclays Bank PLC, BNP Paribas, DNB Capital LLC, Goldman Sachs Bank USA, HSBC Bank USA, National Association, Morgan Stanley Bank, N.A., MUFG Bank, Ltd., Royal Bank of Canada, Sumitomo Mitsui Banking Corporation, Credit Suisse (Switzerland) Ltd., TD Bank, N.A., UniCredit Bank AG (New York Branch), U.S. Bank National Association, DZ Bank AG (New York Branch), The Northern Trust Company, and Lake City Bank.

Staff comments

1. The entirety of the loan contract can be accessed at https://www.sec.gov/Archives/edgar/data/1136869/000119312522226467/d374379dex101.htm 2. Zimmer Biomet Holdings, Inc. is an American medical device company headquartered in Warsaw, Indiana. It designs, develops, manufactures, and markets orthopedic reconstructive products, including joint, dental, and spine implants, as well as related surgical products. 3. AidData estimates the interest rate by adding the 6-month average LIBOR rate in November 2019 and an applicable margin based on Zimmer Biomet’s credit rating at the time (BBB/Baa2 or approximately 1.015%). 4. The individual contributions of the 22 lenders to this $1.5 billion USD syndicated loan are unknown. For the time being, AidData has estimated the contributions of Agricultural Bank of China and Bank of China by assuming that each lender contributed an equal amount ($68,181,818.18 USD) to the loan syndicate.